Results 121 to 130 of about 23,348 (143)

Modulation of TLR4 and upregulation of HO-1 & PPAR-γ by Pioglitazone ameliorates methotrexate-induced liver damage in rats

open access: yesFuture Journal of Pharmaceutical Sciences
Background Methotrexate is a frequently prescribed antifolate immunosuppressant and antineoplastic agent that has been associated with serious systemic adverse effects including hepatotoxicity.
Rasha Abdelhady   +4 more
doaj   +1 more source

Pioglitazone

open access: yesReactions Weekly, 2015
Sanjay, Kalra, Yashdeep, Gupta
openaire   +3 more sources

Pioglitazone

Reactions Weekly, 2016
Pioglitazone is a thiazolidinedione antidiabetic with actions similar to those of rosiglitazone. It is used in the management of type 2 diabetes mellitus and is prepared by reducing 5-[4-[2-(5-ethyl-2-pyridyl)ethoxy]benzilidene]-2,4-thiazolidinedione with sodium borohydride in the presence of a cobalt ion and dimethyl glyoxime. Ultraviolet spectroscopy
A, Al-Majed   +4 more
  +5 more sources

Pioglitazone/Metformin

Drugs, 2006
A fixed-dose pioglitazone/metformin tablet is approved in the US and the EU for the treatment of adult patients with type 2 diabetes mellitus who currently have inadequate glycaemic control with metformin monotherapy. In the US, the combination tablet is also approved for the treatment of adult patients with type 2 diabetes who currently have ...
Emma D, Deeks, Lesley J, Scott
openaire   +2 more sources

Pioglitazone

Reactions Weekly, 2007
C. Day, C.J. Bailey
openaire   +2 more sources

Pioglitazone

Reactions Weekly, 2002
Masashi, Kobayashi   +2 more
  +5 more sources

Pioglitazone

Reactions Weekly, 2008
openaire   +2 more sources

Home - About - Disclaimer - Privacy